Hormone Therapy in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Male hormones can stimulate the growth of prostate cancer cells. Hormone therapy
using flutamide and finasteride may fight prostate cancer by reducing the production of male
hormones.
PURPOSE: Phase II trial to study the effectiveness of flutamide and finasteride in treating
prostate cancer patients with high PSA levels who were previously treated with radiation
therapy or radical prostatectomy.